Laura Sutcliffe
Stock Analyst at Citigroup
(0.58)
# 4,163
Out of 5,149 analysts
11
Total ratings
36.36%
Success rate
-11.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $6.97 | +222.81% | 4 | Feb 24, 2026 | |
| RMD ResMed | Maintains: Buy | $330 → $345 | $258.28 | +33.58% | 4 | Feb 2, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $748.72 | -47.91% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $33.05 | - | 2 | Dec 20, 2019 |
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $6.97
Upside: +222.81%
ResMed
Feb 2, 2026
Maintains: Buy
Price Target: $330 → $345
Current: $258.28
Upside: +33.58%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $748.72
Upside: -47.91%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $33.05
Upside: -